![Sudha Rao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Sudha Rao first degree
Entity | Entity type | Industry | |
---|---|---|---|
EpiAxis Therapeutics Pty Ltd.
![]() EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia.
3
| Holding Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sudha Rao via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ANU Connect Ventures Pty Ltd.
![]() ANU Connect Ventures Pty Ltd. Investment ManagersFinance ANU Connect Ventures Pty Ltd (ANU Connect Ventures) is a venture capital subsidiary of Australian National University founded in 2005. The firm is headquartered in Canberra, Australia. | Investment Managers | Private Equity Investor | |
Beta Therapeutics Pty Ltd.
![]() Beta Therapeutics Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Beta Therapeutics Pty Ltd. develops new diabetes therapeutics based on key discoveries. It generates preventative and potentially curative therapies for the people who suffer from diabetes. The company was founded by Keats Nelms, Chris Parish and Charmaine Simeonovic in 2011 and is headquartered in Canberra, Australia. | Miscellaneous Commercial Services | Director/Board Member | |
ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Compliance Officer | |
Manhattan College | College/University | Undergraduate Degree | |
Pace Law School | College/University | Graduate Degree | |
BlueSphere Bio, Inc.
![]() BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology BlueSphere Bio, Inc. manufactures oncology drugs products. The company was founded by Mark Shlomchik, Warren Shlomchik, and Constantinos Panousis and is headquartered in Pittsburgh, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
ADALTA LIMITED | Biotechnology | Director/Board Member | |
RACE ONCOLOGY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DIMERIX LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
Australia | 6 |
United States | 6 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Commercial Services | 2 |
Health Services | 2 |
Operational
Director/Board Member | 4 |
Chief Executive Officer | 2 |
General Counsel | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Private Equity Investor | 1 |
Most connected contacts
Insiders | |
---|---|
Keir Loiacono | 6 |
David Fuller | 4 |
Jeremy Chrisp | 3 |
- Stock Market
- Insiders
- Sudha Rao
- Company connections